About
DdRNAi
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyBiotech
Team (7)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
46
By Phase
PHASE1/PHASE2: 1PHASE2: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
Today
Hover over trial bars to see details
Recent Trials
NCT06185673Lead Sponsor
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
PHASE1/PHASE2Recruiting
30 participants
Started: Nov 28, 2023 · Completed: Nov 30, 2040
NCT03433027Lead Sponsor
A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2Completed
16 participants
Started: Mar 15, 2018 · Completed: Apr 6, 2020
Locations (1)
Headquarters
Hayward, CA, United States
Map
Loading map...